Mepolizumab treatment alters the functional phenotype of eosinophils in severe eosinophilic asthma
BackgroundBlood eosinophil count is usually employed as a predictive and response biomarker for mepolizumab treatment. However, its decrease is not always associated with an improvement in asthma symptoms. The aim of this work is to study the effect of…